At Utrecht Science Park Bilthoven, we turn scientific discovery into real-world health impact. Guided by the vision 'From Cell to Society,' the park is a unique hub where biomanufacturing, life sciences, and medtech come together to improve health on a global scale.
Building on decades of expertise in vaccine development, biological production, and public health, Utrecht Science Park Bilthoven connects research, technology, and manufacturing in one integrated environment. Here, innovation moves beyond the lab - transforming ideas into vaccines, diagnostics, and technologies that make a tangible difference in people’s lives.
Our focus areas include:
In 2013, site transitioned from public to private ownership, marking a new chapter in its development. In 2016, it was acquired by Poonawalla Science Park B.V., part of the Indian Poonawalla Group.
Through a strategic collaboration with Utrecht Science Park, the site was renamed Utrecht Science Park Bilthoven in 2017, marking a new chapter in its development as a hub for life sciences and biotechnology.
Follow the link to read more about our history.
USPB is home to both long-standing organizations and emerging innovators. For example, Bilthoven Biologicals and Intravacc - both formerly part of RIVM and privatized in 2009 and 2024 respectively - have been part of the campus from the very beginning.
Our newest tenant, Kuros bioscienses, joined us in 2024, adding fresh momentum to our growing life sciences community.
Want to meet our current tenants? Follow the link.